Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation

Abstract

Summary Advanced chronic heart failure (CHF) is associated with abnormal haemostasis and inflammation, but it is not known how these abnormalities are related, whether they are modified by oral anticoagulants (OAT), or if they persist after successful heart transplantation. We studied 25 patients with CHF (New York Heart Association class IV, 10 of whom underwent heart transplantation) and 25 age‐ and sex‐matched healthy controls by measuring their plasma levels of prothrombin fragment 1 + 2 (F1 + 2), thrombin–antithrombin (TAT) complexes, tissue plasminogen activator (t‐PA), plasminogen activator inhibitor‐1 (PAI‐1), D‐dimer, factor VII (FVII), fibrinogen, von Willebrand factor (VWF), tumour necrosis factor (TNF), soluble TNF receptor II (sTNFRII), interleukin 6 (IL‐6), soluble intercellular adhesion molecule‐1 (sICAM‐1), soluble vascular cell adhesion molecule‐1 (sVCAM‐1), endothelial‐selectin (E‐selectin) and thrombomodulin. CHF patients had higher plasma levels of TAT, D‐dimer, t‐PA, fibrinogen, VWF, TNF, IL‐6, sTNFRII, sVCAM‐1 (P = 0·0001), sICAM‐1 (P = 0·003) and thrombomodulin (P = 0·007) than controls. There were significant correlations (r = 0·414–0·595) between coagulation, fibrinolysis, endothelial dysfunction and inflammation parameters, which were lower in those patients treated with OATs. Heart transplantation led to reductions in fibrinogen (P = 0·001), VWF (P = 0·05), D‐dimer (P = 0·05) and IL‐6 levels (P = 0·05), but all the parameters remained significantly higher (P = 0·01–0·0001) than in the controls. Advanced CHF is associated with coagulation activation, endothelial dysfunction and increased proinflammatory cytokine levels. Most of these abnormalities parallel each other, tend to normalize in patients treated with OATs and, although reduced, persist in patients undergoing successful heart transplantation, despite the absence of clinical signs of CHF.

Atorvastatin Improves Endothelial Function and Cardiac Performance in Patients with Dilated Cardiomyopathy: The Role of Inflammation

“…In our patients with nonischemic dilated cardiomyopathy, serum sICAM-1 levels were positively correlated with plasma CRP levels, a marker of systemic inflammation, and with plasma vWF level, a marker of endothelial cell damage. These results are consistent with another report [15]. Combining our results with studies mentioned in the "Introduction" part, we suggest that in such patients upregulated expression of ICAM-1 mediated the adherence of circulating mononuclear cells such as monocytes to the vascular endothelium.…”

Inflammatory markers in stable heart failure and their relationship with functional class

“…Fibrinogen has been widely associated to ischemic heart disease [4,14], and patients with higher levels of this marker have a poorer prognosis. In large studies, fibrinogen has also been associated to a higher rate of embolic events in patients with atrial fibrillation, therefore identifying a subgroup of patients with an increased thrombogenicity [10,15,16]. Our analysis showed greater fibrinogen increases in the overall HF group (as an inflammation marker), but particularly in patients with HF of an ischemic and miscellaneous etiology.…”

Clinical and pathogenetic features of inflammatory and atrophic changes in the gastroduodenal zone in patients with varying severity of chronic heart failure associated with coronary artery disease

“…ВАИ ГДЗ у лиц с тяжелыми застойными явлениями возникали и протекали на фоне выраженных нарушений МЦК в ее тканях по тромбогеморрагическому типу, угнетения вы-работки всех компонентов желудочного секрета и в 63,2% случаев -в присутствии H. рylori. Обобщая данные литературы и результаты нашего ис-следования о состоянии различных звеньев патогенеза ВАИ ГДЗ при ХСН, мы пришли к выводу, что пусковым механизмом их развития следует считать генерализован-ные нарушения нейрогуморальной регуляции, МЦК и ге-мостаза, которые определяются у таких больных [12][13][14]. Их результатом на уровне СО желудка и ДПК являлись хронические рецидивирующие расстройства терминаль-ного кровотока по тромбогеморрагическому типу.…”